{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:32:46Z","timestamp":1791772366301,"version":"4.3.4"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"European Union\u2019s Horizon Training Mobility Actions- Consortium Grant agreement MiCCrobioTAckle","award":["09150182010020"],"award-info":[{"award-number":["09150182010020"]}]},{"name":"NWO VICI grant 2020","award":["09150182010020"],"award-info":[{"award-number":["09150182010020"]}]},{"name":"ERC Advanced grant","award":["101141346"],"award-info":[{"award-number":["101141346"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Nutr"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1186\/s12263-025-00791-8","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:07:06Z","timestamp":1764317226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gut microbiota in cancer cachexia: a new frontier for research and therapy"],"prefix":"10.1186","volume":"20","author":[{"given":"Colleen K.","family":"Ardis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Phuong Nam","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Nieuwdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"791_CR1","unstructured":"Ni J, Zhang L. (2020). Cancer Cachexia: Definition, Staging, and Emerging Treatments. DOAJ (DOAJ: Directory of Open Access Journals). https:\/\/doaj.org\/article\/cef7dbdef11347309ebcd2313f64b14a."},{"issue":"11","key":"791_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s JM, Busquets S, Stemmler B, L\u00f3pez-Soriano FJ. Cancer cachexia: Understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754. https:\/\/doi.org\/10.1038\/nrc3829.","journal-title":"Nat Rev Cancer"},{"key":"791_CR3","doi-asserted-by":"publisher","unstructured":"Marceca GP, Londhe P, Calore F. Management of cancer cachexia: attempting to develop new pharmacological agents for new effective therapeutic options. Front Oncol. 2020;10. https:\/\/doi.org\/10.3389\/fonc.2020.00298.","DOI":"10.3389\/fonc.2020.00298"},{"key":"791_CR4","doi-asserted-by":"publisher","unstructured":"Wang Y, An Z, Lin D, Jin W. Targeting cancer cachexia: molecular mechanisms and clinical study. MedComm. 2022;3(4). https:\/\/doi.org\/10.1002\/mco2.164.","DOI":"10.1002\/mco2.164"},{"key":"791_CR5","doi-asserted-by":"publisher","unstructured":"Donohoe CL, Ryan AM, Reynolds JV. (2011). Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract. 2011:1. https:\/\/doi.org\/10.1155\/2011\/601434.","DOI":"10.1155\/2011\/601434"},{"issue":"9","key":"791_CR6","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00520-010-0972-0","volume":"19","author":"N Bennani-Baiti","year":"2010","unstructured":"Bennani-Baiti N, Walsh D. Animal models of the cancer anorexia\u2013cachexia syndrome. Support Care Cancer. 2010;19(9):1451. https:\/\/doi.org\/10.1007\/s00520-010-0972-0.","journal-title":"Support Care Cancer"},{"issue":"16","key":"791_CR7","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.3390\/ijms22168491","volume":"22","author":"H Nishikawa","year":"2021","unstructured":"Nishikawa H, Goto M, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Cancer cachexia: its mechanism and clinical significance. Int J Mol Sci. 2021;22(16):8491. https:\/\/doi.org\/10.3390\/ijms22168491.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"791_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009;89(2):381. https:\/\/doi.org\/10.1152\/physrev.00016.2008.","journal-title":"Physiol Rev"},{"issue":"8","key":"791_CR9","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.3390\/nu16081246","volume":"16","author":"JV Loyala","year":"2024","unstructured":"Loyala JV, Down B, Wong E, Tan B. Treatment of cachexia in gastric cancer: exploring the use of Anti-Inflammatory natural products and their derivatives. Nutrients. 2024;16(8):1246. https:\/\/doi.org\/10.3390\/nu16081246.","journal-title":"Nutrients"},{"issue":"3","key":"791_CR10","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/ijms24031849","volume":"24","author":"C Panebianco","year":"2023","unstructured":"Panebianco C, Villani A, Potenza A, Favaro E, Finocchiaro C, Perri F, Pazienza V. Targeting gut microbiota in cancer cachexia: towards new treatment options. Int J Mol Sci. 2023;24(3):1849. https:\/\/doi.org\/10.3390\/ijms24031849.","journal-title":"Int J Mol Sci"},{"issue":"24","key":"791_CR11","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.3390\/ijms20246267","volume":"20","author":"KM Herremans","year":"2019","unstructured":"Herremans KM, Riner AN, Cameron ME, Trevi\u00f1o JG. The microbiota and cancer cachexia. Int J Mol Sci. 2019;20(24):6267. https:\/\/doi.org\/10.3390\/ijms20246267.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"791_CR12","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3390\/metabo13091024","volume":"13","author":"D Directo","year":"2023","unstructured":"Directo D, Lee S-R. Cancer cachexia: underlying mechanisms and potential therapeutic interventions. Metabolites. 2023;13(9):1024. https:\/\/doi.org\/10.3390\/metabo13091024.","journal-title":"Metabolites"},{"key":"791_CR13","doi-asserted-by":"publisher","unstructured":"Porporato PE. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis. 2016;5(2). https:\/\/doi.org\/10.1038\/oncsis.2016.3.","DOI":"10.1038\/oncsis.2016.3"},{"issue":"4","key":"791_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/01.mco.0000078983.18774.cc","volume":"6","author":"JM Argil\u00e9s","year":"2003","unstructured":"Argil\u00e9s JM, Busquets S, L\u00f3pez-Soriano FJ. Cytokines in the pathogenesis of cancer cachexia. Curr Opin Clin Nutr Metabolic Care. 2003;6(4):401. https:\/\/doi.org\/10.1097\/01.mco.0000078983.18774.cc.","journal-title":"Curr Opin Clin Nutr Metabolic Care"},{"issue":"3","key":"791_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jcsm.12528","volume":"11","author":"SP da Silva","year":"2020","unstructured":"da Silva SP, Santos J, e Silva MPC, da Costa RMG, Medeiros R. Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle. 2020;11(3):619. https:\/\/doi.org\/10.1002\/jcsm.12528.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"791_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","volume":"7","author":"T Aoyagi","year":"2015","unstructured":"Aoyagi T, Terracina KP, Raza A, Matsubara H, Takabe K. Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol. 2015;7(4):17. https:\/\/doi.org\/10.4251\/wjgo.v7.i4.17.","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"791_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jpen.2287","volume":"42","author":"OU Gaafer","year":"2021","unstructured":"Gaafer OU, Zimmers TA. The nutritional challenges of cancer cachexia. J Parenter Enter Nutr. 2021;42(2):16. https:\/\/doi.org\/10.1002\/jpen.2287.","journal-title":"J Parenter Enter Nutr"},{"key":"791_CR18","doi-asserted-by":"publisher","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4(1). https:\/\/doi.org\/10.1038\/nrdp.2017.105.","DOI":"10.1038\/nrdp.2017.105"},{"issue":"12","key":"791_CR19","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3390\/life13122317","volume":"13","author":"E Sasso","year":"2023","unstructured":"Sasso E, Bati\u010di\u0107 L, Tokmad\u017ei\u0107 VS. Postprandial dysmetabolism and its medical implications. Life. 2023;13(12):2317. https:\/\/doi.org\/10.3390\/life13122317.","journal-title":"Life"},{"issue":"5","key":"791_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.276733.115","volume":"30","author":"M Petruzzelli","year":"2016","unstructured":"Petruzzelli M, Wagner EF. Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev. 2016;30(5):489. https:\/\/doi.org\/10.1101\/gad.276733.115.","journal-title":"Genes Dev"},{"issue":"8","key":"791_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/nu8080499","volume":"8","author":"AM Horstman","year":"2016","unstructured":"Horstman AM, Damink SWMO, Schols AMWJ, van Loon LJC. Is cancer cachexia attributed to impairments in basal or postprandial muscle protein metabolism? Nutrients. 2016;8(8):499. https:\/\/doi.org\/10.3390\/nu8080499.","journal-title":"Nutrients"},{"issue":"1","key":"791_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21037\/apm.2018.10.01","volume":"8","author":"S Dalal","year":"2018","unstructured":"Dalal S. Lipid metabolism in cancer cachexia. Annals Palliat Med. 2018;8(1):13. https:\/\/doi.org\/10.21037\/apm.2018.10.01.","journal-title":"Annals Palliat Med"},{"issue":"1","key":"791_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s43440-020-00179-y","volume":"73","author":"T Masi","year":"2020","unstructured":"Masi T, Patel BM. Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison. Pharmacol Rep. 2020;73(1):17. https:\/\/doi.org\/10.1007\/s43440-020-00179-y.","journal-title":"Pharmacol Rep"},{"issue":"1","key":"791_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev-nutr-062122-015646","volume":"44","author":"SLE Compton","year":"2024","unstructured":"Compton SLE, Heymsfield SB, Brown JC. Nutritional mechanisms of cancer cachexia. Annu Rev Nutr. 2024;44(1):77. https:\/\/doi.org\/10.1146\/annurev-nutr-062122-015646.","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"791_CR25","doi-asserted-by":"publisher","first-page":"165576","DOI":"10.1016\/j.bbadis.2019.165576","volume":"1866","author":"Q Xie","year":"2019","unstructured":"Xie Q, Zhu Z, He Y, Zhang Z, Zhang Y, Wang Y, Luo J, Peng T, Cheng F, Gao J, Cao Y, Wei H, Wu Z. A lactate-induced Snail\/STAT3 pathway drives GPR81 expression in lung cancer cells. Biochim Et Biophys Acta (BBA) - Mol Basis Disease. 2019;1866(1):165576. https:\/\/doi.org\/10.1016\/j.bbadis.2019.165576.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Disease"},{"issue":"4","key":"791_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s42255-024-01011-0","volume":"6","author":"X Liu","year":"2024","unstructured":"Liu X, Li S, Cui Q, Guo B, Ding W, Liu J, Li Q, Li X, Xie P, Jin L, Ye S, Chen W, Wang K, Zeng F, Qiu Y, Liu C, Zhang Y, Lv F, Hu X, Xiao R. Activation of GPR81 by lactate drives tumour-induced cachexia. Nat Metabolism. 2024;6(4):708. https:\/\/doi.org\/10.1038\/s42255-024-01011-0.","journal-title":"Nat Metabolism"},{"issue":"9","key":"791_CR27","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.3390\/ijms22094501","volume":"22","author":"Z Cao","year":"2021","unstructured":"Cao Z, Zhao K, Jose I, Hoogenraad N, Osellame LD. Biomarkers for cancer cachexia: A mini review. Int J Mol Sci. 2021;22(9):4501. https:\/\/doi.org\/10.3390\/ijms22094501.","journal-title":"Int J Mol Sci"},{"key":"791_CR28","doi-asserted-by":"publisher","unstructured":"Zhu X, Starosta S, Ferrer M, Hou JY, Chevy Q, Lucantonio F, Mu\u00f1oz-Casta\u00f1eda R, Zhang F, Zang K, Zhao X, Fiocchi FR, Bergstr\u00f6m M, Siebels AA, Upin T, Wulf M, Evans SH, Kravitz AV, Osten P, Janowitz T, Kepecs \u00c1. A neuroimmune circuit mediates cancer cachexia-associated apathy. Science. 2025;388(6743). https:\/\/doi.org\/10.1126\/science.adm8857.","DOI":"10.1126\/science.adm8857"},{"issue":"9","key":"791_CR29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41574-024-00992-y","volume":"20","author":"HT Langer","year":"2024","unstructured":"Langer HT, Rohm M, Goncalves MD, Sylow L. AMPK as a mediator of tissue preservation: time for a shift in dogma? Nat Reviews Endocrinol. 2024;20(9):526. https:\/\/doi.org\/10.1038\/s41574-024-00992-y.","journal-title":"Nat Reviews Endocrinol"},{"key":"791_CR30","doi-asserted-by":"publisher","unstructured":"Rohm M, Zeigerer A, Machado J, Herzig S. Energy metabolism in cachexia. EMBO Rep. 2019;20(4). https:\/\/doi.org\/10.15252\/embr.201847258.","DOI":"10.15252\/embr.201847258"},{"key":"791_CR31","doi-asserted-by":"publisher","unstructured":"Marceca GP, Nigita G, Calore F, Croce CM. MicroRNAs in skeletal muscle and hints on their potential role in muscle wasting during cancer cachexia. Front Oncol. 2020;10. https:\/\/doi.org\/10.3389\/fonc.2020.607196.","DOI":"10.3389\/fonc.2020.607196"},{"issue":"4","key":"791_CR32","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/cancers12041004","volume":"12","author":"J Santos","year":"2020","unstructured":"Santos J, Silva SP, da, Costa RMG, da, Medeiros R. The emerging role of MicroRNAs and other Non-Coding RNAs in cancer cachexia. Cancers. 2020;12(4):1004. https:\/\/doi.org\/10.3390\/cancers12041004.","journal-title":"Cancers"},{"issue":"3","key":"791_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/mco.0000000000000645","volume":"23","author":"AJ Sannicandro","year":"2020","unstructured":"Sannicandro AJ, McDonagh B, Goljanek-Whysall K. MicroRNAs as potential therapeutic targets for muscle wasting during cancer cachexia. Curr Opin Clin Nutr Metabolic Care. 2020;23(3):157. https:\/\/doi.org\/10.1097\/mco.0000000000000645.","journal-title":"Curr Opin Clin Nutr Metabolic Care"},{"key":"791_CR34","doi-asserted-by":"publisher","unstructured":"Chen R, Lei S, Jiang T, She Y, Shi H. Regulation of skeletal muscle atrophy in cachexia by microRNAs and long non-coding RNAs. Front Cell Dev Biol. 2020;8. https:\/\/doi.org\/10.3389\/fcell.2020.577010.","DOI":"10.3389\/fcell.2020.577010"},{"issue":"2","key":"791_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.22088\/cjim.12.2.124","volume":"12","author":"N Sutandyo","year":"2021","unstructured":"Sutandyo N. The role of MicroRNA in cancer cachexia and muscle wasting: A review Article. DOAJ (DOAJ: Directory Open Access Journals). 2021;12(2):124. https:\/\/doi.org\/10.22088\/cjim.12.2.124.","journal-title":"DOAJ (DOAJ: Directory Open Access Journals)"},{"issue":"8","key":"791_CR36","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.3390\/ijms20081962","volume":"20","author":"PP Freire","year":"2019","unstructured":"Freire PP, Fern\u00e1ndez GJ, Cury SS, Moraes Dde, Oliveira JS, Oliveira Gde, Dal-Pai\u2010Silva M, Reis PP, Carvalho RF. The pathway to cancer cachexia: MicroRNA-Regulated networks in muscle wasting based on integrative Meta-Analysis. Int J Mol Sci. 2019;20(8):1962. https:\/\/doi.org\/10.3390\/ijms20081962.","journal-title":"Int J Mol Sci"},{"issue":"24","key":"791_CR37","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/nejmra1600266","volume":"375","author":"SV Lynch","year":"2016","unstructured":"Lynch SV, Pedersen O. The human intestinal Microbiome in health and disease. N Engl J Med. 2016;375(24):2369. https:\/\/doi.org\/10.1056\/nejmra1600266.","journal-title":"N Engl J Med"},{"key":"791_CR38","doi-asserted-by":"publisher","unstructured":"Kouidhi S, Zidi O, Belkhiria Z, Ra\u00efs H, Ayadi A, Ayed FB, Mosbah A, Ch\u00e9rif A, Gaaied AB, A. E. Gut microbiota, an emergent target to shape the efficiency of cancer therapy. Explor Target Antitumor Ther. 2023;240. https:\/\/doi.org\/10.37349\/etat.2023.00132.","DOI":"10.37349\/etat.2023.00132"},{"key":"791_CR39","doi-asserted-by":"publisher","unstructured":"Hul MV, Neyrinck AM, Everard A, Abot A, Bindels LB, Delzenne NM, Knauf C, Cani PD. Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities. Clin Microbiol Rev. 2024;37(3). https:\/\/doi.org\/10.1128\/cmr.00045-23.","DOI":"10.1128\/cmr.00045-23"},{"issue":"3","key":"791_CR40","doi-asserted-by":"publisher","first-page":"101508","DOI":"10.1016\/j.beem.2021.101508","volume":"35","author":"J Ziemons","year":"2021","unstructured":"Ziemons J, Smidt ML, Damink SWMO, Rensen SS. Gut microbiota and metabolic aspects of cancer cachexia. Best Pract Res Clin Endocrinol Metab. 2021;35(3):101508. https:\/\/doi.org\/10.1016\/j.beem.2021.101508.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11","key":"791_CR41","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1038\/s41396-021-00998-8","volume":"15","author":"Y Ni","year":"2021","unstructured":"Ni Y, Lohinai Z, Heshiki Y, D\u00f6me B, Moldvay J, Dulka E, G\u00e1lffy G, Berta J, Weiss GJ, Sommer MOA, Panagiotou G. Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients. ISME J. 2021;15(11):3207. https:\/\/doi.org\/10.1038\/s41396-021-00998-8.","journal-title":"ISME J"},{"key":"791_CR42","doi-asserted-by":"publisher","unstructured":"Malard F, Vekhoff A, Lapusan S, Isnard F, D\u2019incan-Corda E, Rey J, Saillard C, Thomas X, Ducastelle-Lepr\u00eatre S, Paubelle \u00c9, Larcher M, Rocher C, R\u00e9cher C, Tavitian S, Bertoli S, Michallet A, Gilis L, P\u00e9terlin P, Chevallier P, Mohty M. Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients. Nat Commun. 2021;12(1). https:\/\/doi.org\/10.1038\/s41467-021-23376-6.","DOI":"10.1038\/s41467-021-23376-6"},{"issue":"11","key":"791_CR43","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.clnu.2023.09.021","volume":"42","author":"SA P\u00f6tgens","year":"2023","unstructured":"P\u00f6tgens SA, Lecop S, Havelange V, Li F, Neyrinck AM, Neveux N, Maertens J, Walter J, Schoemans H, Delzenne NM, Bindels LB. Gut microbiota alterations induced by intensive chemotherapy in acute myeloid leukaemia patients are associated with gut barrier dysfunction and body weight loss. Clin Nutr. 2023;42(11):2214. https:\/\/doi.org\/10.1016\/j.clnu.2023.09.021.","journal-title":"Clin Nutr"},{"key":"791_CR44","doi-asserted-by":"publisher","unstructured":"Ilozumba MN, Lin T, Hardikar S, Byrd DA, Round JL, Stephens WZ, Holowatyj AN, Warby CA, Damerell V, Li CI, Figueiredo JC, Toriola AT, Shibata D, Fillmore GC, Pickron B, Siegel EM, Kahlert C, Florou V, Gigic B, et al. Fusobacterium nucleatum abundance is associated with cachexia in colorectal cancer patients: the ColoCare Study. Cancer Med. 2024;13(22). https:\/\/doi.org\/10.1002\/cam4.70431.","DOI":"10.1002\/cam4.70431"},{"key":"791_CR45","doi-asserted-by":"publisher","unstructured":"P\u00f6tgens SA, Brossel H, Sboarina M, Catry \u00c9, Cani PD, Neyrinck AM, Delzenne NM, Bindels LB. Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction. Sci Rep. 2018;8(1). https:\/\/doi.org\/10.1038\/s41598-018-30569-5.","DOI":"10.1038\/s41598-018-30569-5"},{"key":"791_CR46","doi-asserted-by":"publisher","first-page":"107476","DOI":"10.1016\/j.phrs.2024.107476","volume":"209","author":"J Wu","year":"2024","unstructured":"Wu J, Zhang R, Yin Z, Chen X, Mao R, Zheng X, Yuan M, Li H, Lu Y, Liu S, Gao XJ, Sun Q. Gut microbiota-driven metabolic alterations reveal the distinct pathogenicity of chemotherapy-induced cachexia in gastric cancer. Pharmacol Res. 2024;209:107476. https:\/\/doi.org\/10.1016\/j.phrs.2024.107476.","journal-title":"Pharmacol Res"},{"issue":"21","key":"791_CR47","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.3390\/cancers14215405","volume":"14","author":"T Hakozaki","year":"2022","unstructured":"Hakozaki T, Nolin-Lapalme A, Kogawa M, Okuma Y, Nakamura S, Moreau-Amaru D, Tamura T, Hosomi Y, Takeyama H, Richard C, Hosokawa M, Routy B. Cancer cachexia among patients with advanced Non-Small-Cell lung cancer on immunotherapy: an observational study with exploratory gut microbiota analysis. Cancers. 2022;14(21):5405. https:\/\/doi.org\/10.3390\/cancers14215405.","journal-title":"Cancers"},{"key":"791_CR48","doi-asserted-by":"publisher","first-page":"12090","DOI":"10.1200\/jco.2024.42.16_suppl.12090","volume":"42","author":"T Hakozaki","year":"2024","unstructured":"Hakozaki T, Salazar EM, Kobayashi T, Fukuoka S, Koyama S, Nishikawa H, Motooka D, Nakamura S, Okuma Y, Hosomi Y, Takeyama H, Hosokawa M, Routy B. Novel screening approach for cancer cachexia using metagenomic gut Microbiome profiling in patients with advanced non-small cell lung cancer. J Clin Oncol. 2024;42:12090. https:\/\/doi.org\/10.1200\/jco.2024.42.16_suppl.12090.","journal-title":"J Clin Oncol"},{"issue":"5","key":"791_CR49","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/microorganisms9051071","volume":"9","author":"Y Bai","year":"2021","unstructured":"Bai Y, Zhou X, Li N, Zhao J, Ye H, Zhang S, Yang H, Pi Y, Tao S, Han D, Zhang S, Wang J. Vitro fermentation characteristics and Fiber-Degrading enzyme kinetics of Cellulose, Arabinoxylan, \u03b2-Glucan and glucomannan by pig fecal microbiota. Microorganisms. 2021;9(5):1071. https:\/\/doi.org\/10.3390\/microorganisms9051071.","journal-title":"Microorganisms"},{"issue":"6","key":"791_CR50","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/jcsm.12798","volume":"12","author":"L Feng","year":"2021","unstructured":"Feng L, Zhang W, Shen Q, Miao C, Chen L, Li Y, Gu X, Fan M, Ma Y, Wang H, Liu X, Zhang X. Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut Microbiome. J Cachexia Sarcopenia Muscle. 2021;12(6):1553. https:\/\/doi.org\/10.1002\/jcsm.12798.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"18","key":"791_CR51","doi-asserted-by":"publisher","first-page":"8075","DOI":"10.26355\/eurrev_201909_19024","volume":"23","author":"IG Macchione","year":"2019","unstructured":"Macchione IG, Lopetuso LR, Ianiro G, Napoli M, Gibiino G, Rizzatti G, Petito V, Gasbarrini A, Scaldaferri F. Akkermansia muciniphila: key player in metabolic and Gastrointestinal disorders. PubMed. 2019;23(18):8075. https:\/\/doi.org\/10.26355\/eurrev_201909_19024.","journal-title":"PubMed"},{"issue":"5","key":"791_CR52","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1111\/cas.15306","volume":"113","author":"T Sakakida","year":"2022","unstructured":"Sakakida T, Ishikawa T, Doi T, Morita R, Endo Y, Matsumura S, Ota T, Yoshida J, Hirai Y, Mizushima K, Higashimura Y, Inoue K, Okayama T, Uchiyama K, Takagi T, Abe A, Inoue R, Itoh Y, Naito Y. Water- soluble dietary fiber alleviates cancer- induced muscle wasting through changes in gut microenvironment in mice. Cancer Sci. 2022;113(5):1789. https:\/\/doi.org\/10.1111\/cas.15306.","journal-title":"Cancer Sci"},{"key":"791_CR53","doi-asserted-by":"publisher","unstructured":"Belzer C, Chia LW, Aalvink S, Chamlagain B, Piironen V, Knol J, de Vos WM. Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B12 production by intestinal symbionts. mBio. 2017;8(5). https:\/\/doi.org\/10.1128\/mbio.00770-17.","DOI":"10.1128\/mbio.00770-17"},{"key":"791_CR54","doi-asserted-by":"publisher","unstructured":"Gubernatorova EO, \u0413\u043e\u0440\u0448\u043a\u043e\u0432\u0430 \u0415\u0410, Bondareva M, Podosokorskaya OA, Sheynova AD, Yakovleva AS, Bonch-Osmolovskaya EA, Nedospasov SA, Kruglov A, Drutskaya MS. Akkermansia muciniphila - friend or foe in colorectal cancer? Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1303795.","DOI":"10.3389\/fimmu.2023.1303795"},{"key":"791_CR55","doi-asserted-by":"publisher","first-page":"106332","DOI":"10.1016\/j.micpath.2023.106332","volume":"183","author":"H Liu","year":"2023","unstructured":"Liu H, Cheng Y-X, Qu Y, Wu G. Unraveling the gut microbiota and short-chain fatty acids characteristics and associations in a cancer cachexia mouse model. Microb Pathog. 2023;183:106332. https:\/\/doi.org\/10.1016\/j.micpath.2023.106332.","journal-title":"Microb Pathog"},{"key":"791_CR56","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Reytor D, Puebla C, Karahanian E, Garc\u00eda K. Use of short-chain fatty acids for the recovery of the intestinal epithelial barrier affected by bacterial toxins. Front Physiol. 2021;12. https:\/\/doi.org\/10.3389\/fphys.2021.650313.","DOI":"10.3389\/fphys.2021.650313"},{"key":"791_CR57","doi-asserted-by":"publisher","first-page":"111001","DOI":"10.1016\/j.intimp.2023.111001","volume":"124","author":"H Liu","year":"2023","unstructured":"Liu H, Xi Q, Tan S, Qu Y, Meng Q, Zhang Y, Cheng Y-X, Wu G. The metabolite butyrate produced by gut microbiota inhibits cachexia-associated skeletal muscle atrophy by regulating intestinal barrier function and macrophage polarization. Int Immunopharmacol. 2023;124:111001. https:\/\/doi.org\/10.1016\/j.intimp.2023.111001.","journal-title":"Int Immunopharmacol"},{"issue":"26","key":"791_CR58","doi-asserted-by":"publisher","first-page":"18224","DOI":"10.18632\/oncotarget.24804","volume":"9","author":"LB Bindels","year":"2018","unstructured":"Bindels LB, Neyrinck AM, Loumaye A, Catry \u00c9, Walgrave H, Cherbuy C, Leclercq S, Hul MV, Plovier H, Pachikian BD, Berm\u00fadez-Humar\u00e1n LG, Langella P, Cani PD, Thissen J, Delzenne NM. Increased gut permeability in cancer cachexia: mechanisms and clinical relevance. Oncotarget. 2018;9(26):18224. https:\/\/doi.org\/10.18632\/oncotarget.24804.","journal-title":"Oncotarget"},{"issue":"4","key":"791_CR59","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/SPC.0000000000000017","volume":"7","author":"GL Klein","year":"2013","unstructured":"Klein GL, Petschow BW, Shaw AL, Weaver E. Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target. Curr Opin Support Palliat Care. 2013;7(4):361. https:\/\/doi.org\/10.1097\/SPC.0000000000000017.","journal-title":"Curr Opin Support Palliat Care"},{"key":"791_CR60","doi-asserted-by":"publisher","unstructured":"Genton L, Mareschal J, Charretier Y, Lazarevi\u0107 V, Bindels LB, Schrenzel J. Targeting the gut microbiota to treat cachexia. Front Cell Inf Microbiol. 2019:9. https:\/\/doi.org\/10.3389\/fcimb.2019.00305.","DOI":"10.3389\/fcimb.2019.00305"},{"issue":"6","key":"791_CR61","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3390\/microorganisms13061356","volume":"13","author":"S Roy","year":"2025","unstructured":"Roy S, Bahmani AHA, Davids M, Herrema H, Nieuwdorp M. Modulating the gut\u2013Muscle axis: increasing SCFA-Producing gut microbiota commensals and decreasing endotoxin production to mitigate cancer cachexia. Microorganisms. 2025;13(6):1356. https:\/\/doi.org\/10.3390\/microorganisms13061356.","journal-title":"Microorganisms"},{"issue":"24","key":"791_CR62","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.3390\/cancers13246389","volume":"13","author":"MM Thibaut","year":"2021","unstructured":"Thibaut MM, Gillard J, Dolly A, Roumain M, Leclercq I, Delzenne NM, Muccioli GG, Bindels LB. Bile acid dysregulation is intrinsically related to cachexia in Tumor-Bearing mice. Cancers. 2021;13(24):6389. https:\/\/doi.org\/10.3390\/cancers13246389.","journal-title":"Cancers"},{"key":"791_CR63","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.yclnex.2015.11.001","volume":"6","author":"LB Bindels","year":"2015","unstructured":"Bindels LB, Thissen J-P. Nutrition in cancer patients with cachexia: A role for the gut microbiota? Clin Nutr Experimental. 2015;6:74. https:\/\/doi.org\/10.1016\/j.yclnex.2015.11.001.","journal-title":"Clin Nutr Experimental"},{"key":"791_CR64","doi-asserted-by":"publisher","unstructured":"Ubachs J, Ziemons J, Soons Z, Aarnoutse R, van Dijk DPJ, Penders J, van Helvoort A, Smidt ML, Kruitwagen RFPM, Baade-Corpelijn L, Damink SWMO, Rensen SS. (2021). Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients. J Cachexia Sarcopenia Muscle. 2007;12(6). https:\/\/doi.org\/10.1002\/jcsm.12804.","DOI":"10.1002\/jcsm.12804"},{"key":"791_CR65","doi-asserted-by":"publisher","unstructured":"VanderVeen BN, Cardaci TD, Bullard BM, Madden M, Li J, Velazquez KT, Kubinak JL, Fan D, Murphy EA. Mechanisms underlying diversity in cancer cachexia involvement of the gut microbiota in cancer cachexia. 2024;327(3):C661. https:\/\/doi.org\/10.1152\/ajpcell.00327.2024.","DOI":"10.1152\/ajpcell.00327.2024"},{"issue":"14","key":"791_CR66","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.3390\/jcm11144119","volume":"11","author":"M Biazzo","year":"2022","unstructured":"Biazzo M, Deidda G. Fecal microbiota transplantation as new therapeutic avenue for human diseases. J Clin Med. 2022;11(14):4119. https:\/\/doi.org\/10.3390\/jcm11144119.","journal-title":"J Clin Med"},{"issue":"13","key":"791_CR67","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1158\/1078-0432.ccr-20-4918","volume":"27","author":"NC de Clercq","year":"2021","unstructured":"de Clercq NC, Ende T, van den, Prodan A, Hemke R, Davids M, Pedersen HK, Nielsen HB, Groen AK, de Vos WM, van Laarhoven HWM, Nieuwdorp M. Fecal microbiota transplantation from overweight or obese donors in cachectic patients with advanced gastroesophageal cancer: A Randomized, Double-blind, Placebo-Controlled, phase II study. Clin Cancer Res. 2021;27(13):3784. https:\/\/doi.org\/10.1158\/1078-0432.ccr-20-4918.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"791_CR68","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00280-020-04060-w","volume":"85","author":"H Chen","year":"2020","unstructured":"Chen H, Xu C, Zhang F, Liu Y, Guo Y, Yao Q. The gut microbiota attenuates muscle wasting by regulating energy metabolism in chemotherapy-induced malnutrition rats. Cancer Chemother Pharmacol. 2020;85(6):1049. https:\/\/doi.org\/10.1007\/s00280-020-04060-w.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"791_CR69","doi-asserted-by":"publisher","first-page":"11803","DOI":"10.18632\/oncotarget.7730","volume":"7","author":"BJ Varian","year":"2016","unstructured":"Varian BJ, Goureshetti S, Poutahidis T, Lakritz JR, Levkovich T, Kwok C, Teliousis K, Ibrahim YM, Mirabal S, Erdman SE. Beneficial bacteria inhibit cachexia. Oncotarget. 2016;7(11):11803. https:\/\/doi.org\/10.18632\/oncotarget.7730.","journal-title":"Oncotarget"},{"issue":"6","key":"791_CR70","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/ismej.2015.209","volume":"10","author":"LB Bindels","year":"2016","unstructured":"Bindels LB, Neyrinck AM, Claus SP, Roy CL, Grangette C, Pot B, Mart\u00ednez I, Walter J, Cani PD, Delzenne NM. Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia. ISME J. 2016;10(6):1456. https:\/\/doi.org\/10.1038\/ismej.2015.209.","journal-title":"ISME J"},{"issue":"7","key":"791_CR71","doi-asserted-by":"publisher","first-page":"404","DOI":"10.5483\/bmbrep.2023-0068","volume":"56","author":"SM Jeong","year":"2023","unstructured":"Jeong SM, Jin E, Wei S, Bae J, Ji Y, Jo Y, Jeong J, Im SJ, Ryu D. The impact of cancer cachexia on gut microbiota composition and short-chain fatty acid metabolism in a murine model. BMB Rep. 2023;56(7):404. https:\/\/doi.org\/10.5483\/bmbrep.2023-0068.","journal-title":"BMB Rep"},{"key":"791_CR72","doi-asserted-by":"publisher","unstructured":"Yin Y, Sripetchwandee J, Chattipakorn N, Chattipakorn SC. The alterations of microbiota and pathological conditions in the gut of patients with colorectal cancer undergoing chemotherapy. Anaerobe. 2021;68. https:\/\/doi.org\/10.1016\/j.anaerobe.2021.102361.","DOI":"10.1016\/j.anaerobe.2021.102361"},{"key":"791_CR73","doi-asserted-by":"publisher","unstructured":"Wei L, Wen X, Xian CJ. Chemotherapy-induced intestinal microbiota dysbiosis impairs mucosal homeostasis by modulating toll-like receptor signaling pathways. Int J Mol Sci. 2021;22(17). https:\/\/doi.org\/10.3390\/ijms22179474.","DOI":"10.3390\/ijms22179474"},{"key":"791_CR74","doi-asserted-by":"publisher","unstructured":"Ting NL-N, Lau HC-H, Yu J. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes. Gut. 2022;71(7). https:\/\/doi.org\/10.1136\/gutjnl-2021-326264.","DOI":"10.1136\/gutjnl-2021-326264"},{"key":"791_CR75","doi-asserted-by":"publisher","unstructured":"Yang S, Hao S, Ye H, Zhang X. Crosstalk between gut microbiota and cancer chemotherapy: current status and trends. Discov Oncol. 2024;15(1). https:\/\/doi.org\/10.1007\/s12672-024-01704-8.","DOI":"10.1007\/s12672-024-01704-8"},{"key":"791_CR76","doi-asserted-by":"publisher","unstructured":"Li W, Deng X, Chen T. Exploring the modulatory effects of gut microbiota in anti-cancer therapy. Front Oncol. 2021;11. https:\/\/doi.org\/10.3389\/fonc.2021.644454.","DOI":"10.3389\/fonc.2021.644454"},{"key":"791_CR77","doi-asserted-by":"publisher","unstructured":"Viaud S, Saccheri F, Mignot G, Yamazaki T, Daill\u00e8re R, Hannani D, Enot D, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Ap\u00e9toh L, Chachaty \u00c9, Woerther P, Eberl G, B\u00e9rard M, Ecobichon C, Clermont D, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342(6161). https:\/\/doi.org\/10.1126\/science.1240537.","DOI":"10.1126\/science.1240537"},{"key":"791_CR78","doi-asserted-by":"publisher","unstructured":"Sougiannis AT, VanderVeen BN, Davis JM, Fan D, Murphy EA. Understanding chemotherapy-induced intestinal mucositis and strategies to improve gut resilience. Am J Physiol Gastrointest Liver Physiol. 2021;320(5). https:\/\/doi.org\/10.1152\/ajpgi.00380.2020.","DOI":"10.1152\/ajpgi.00380.2020"},{"key":"791_CR79","doi-asserted-by":"publisher","unstructured":"Maddern AS, Coller JK, Bowen JM, Gibson RJ. The association between the gut microbiome and development and progression of cancer treatment adverse effects. Cancers. 2023;15(17). https:\/\/doi.org\/10.3390\/cancers15174301.","DOI":"10.3390\/cancers15174301"},{"key":"791_CR80","doi-asserted-by":"publisher","unstructured":"Lee KA, Thomas AM, Bolte LA, Bj\u00f6rk JR, de Ruijter LK, Armanini F, Asnicar F, Blanco-M\u00edguez A, Board R, Calbet-Llopart N, Derosa L, Dhomen N, Brooks K, Harland M, Harries M, Leeming ER, Lorigan P, Manghi P, Marais R, et al. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma. Nat Med. 2022;28(3). https:\/\/doi.org\/10.1038\/s41591-022-01695-5.","DOI":"10.1038\/s41591-022-01695-5"},{"key":"791_CR81","doi-asserted-by":"publisher","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondrag\u00f3n L, Jacquelot N, Qu B, et al. Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors. Science. 2017;359(6371). https:\/\/doi.org\/10.1126\/science.aan3706.","DOI":"10.1126\/science.aan3706"},{"key":"791_CR82","doi-asserted-by":"publisher","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman KL, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, de Mac\u00eado MP, Cotechini T, Kumar T, Chen WS, et al. Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients. Science. 2017;359(6371). https:\/\/doi.org\/10.1126\/science.aan4236.","DOI":"10.1126\/science.aan4236"},{"key":"791_CR83","doi-asserted-by":"publisher","unstructured":"Ciernikova S, Sevcikova A, Novisedl\u00e1kov\u00e1 M, Mego M. Insights into the relationship between the gut microbiome and immune checkpoint inhibitors in solid tumors. Cancers. 2024;16(24). https:\/\/doi.org\/10.3390\/cancers16244271.","DOI":"10.3390\/cancers16244271"},{"key":"791_CR84","doi-asserted-by":"publisher","unstructured":"Najafi S, Majidpoor J, Mortezaee K. The impact of microbiota on PD-1\/PD-L1 inhibitor therapy outcomes: a focus on solid tumors. Life Sci. 2022;310. https:\/\/doi.org\/10.1016\/j.lfs.2022.121138.","DOI":"10.1016\/j.lfs.2022.121138"},{"key":"791_CR85","doi-asserted-by":"publisher","unstructured":"Bredon M, Danne C, Pham H, Ruffi\u00e9 P, Bessede A, Rolhion N, Creusot L, Brot L, Alonso I, Langella P, Derosa L, Cortot AB, Routy B, Zitvogel L, Segata N, Sokol H. Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors. OncoImmunology. 2024;13(1). https:\/\/doi.org\/10.1080\/2162402x.2024.2374954.","DOI":"10.1080\/2162402x.2024.2374954"},{"issue":"2","key":"791_CR86","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","volume":"28","author":"L Derosa","year":"2022","unstructured":"Derosa L, Routy B, Thomas AM, Iebba V, Zalcman G, Friard S. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 Blockade in patients with advanced non-small-cell lung cancer. Nat Med. 2022;28(2):315. https:\/\/doi.org\/10.1038\/s41591-021-01655-5.","journal-title":"Nat Med"},{"key":"791_CR87","doi-asserted-by":"publisher","unstructured":"Zhou G, Zhang N, Meng K, Pan F. Interaction between gut microbiota and immune checkpoint inhibitor-related colitis. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.1001623.","DOI":"10.3389\/fimmu.2022.1001623"},{"key":"791_CR88","doi-asserted-by":"publisher","unstructured":"Han X, Zang D, Liu D, Chen J. The multifaceted roles of common gut microbiota in immune checkpoint inhibitor-mediated colitis: from mechanism to clinical application. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.988849.","DOI":"10.3389\/fimmu.2022.988849"},{"key":"791_CR89","doi-asserted-by":"publisher","unstructured":"Takada K, Yoneshima Y, Tanaka K, Okamoto I, Shimokawa M, Wakasu S, Takamori S, Toyokawa G, Oba T, Osoegawa A, Tagawa T, Oda Y, Nakanishi Y, Mori M. Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors. J Cancer Res Clin Oncol. 2020;146(5). https:\/\/doi.org\/10.1007\/s00432-020-03146-5.","DOI":"10.1007\/s00432-020-03146-5"},{"issue":"5","key":"791_CR90","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/sj.bjc.6604905","volume":"100","author":"K van Norren","year":"2009","unstructured":"van Norren K, Kegler D, Argil\u00e9s JM, Luiking YC, Gorselink M, Laviano A, Arts K, Faber J, Jansen H, van der Beek EM, van Helvoort A. Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer. 2009;100(5):713. https:\/\/doi.org\/10.1038\/sj.bjc.6604905.","journal-title":"Br J Cancer"},{"issue":"7","key":"791_CR91","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3390\/nu12072029","volume":"12","author":"B Oberm\u00fcller","year":"2020","unstructured":"Oberm\u00fcller B, Singer G, Kienesberger B, Klymiuk I, Sperl D, Stadlbauer V, Horvath A, Miekisch W, Gierschner P, Grabherr R, Gruber H, Semeraro MD, Till H, Castellani C. The effects of prebiotic supplementation with OMNi-LOGiC\u00ae FIBRE on fecal Microbiome, fecal volatile organic Compounds, and gut permeability in murine Neuroblastoma-Induced Tumor-Associated cachexia. Nutrients. 2020;12(7):2029. https:\/\/doi.org\/10.3390\/nu12072029.","journal-title":"Nutrients"},{"key":"791_CR92","doi-asserted-by":"publisher","unstructured":"Huang G, Khan I, Li X, Chen L, Leong WY, Ho LT, Hsiao WLW. Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin\/+ mice. Sci Rep. 2017;7(1). https:\/\/doi.org\/10.1038\/s41598-017-12644-5.","DOI":"10.1038\/s41598-017-12644-5"},{"key":"791_CR93","doi-asserted-by":"publisher","unstructured":"Bindels LB, Neyrinck AM, Salazar N, Taminiau B, Druart C, Muccioli GG, Fran\u00e7ois E, Blecker C, Richel A, Daube G, Mahillon J, de Reyes-Gavil\u00e1n CG los, Cani PD, Delzenne NM. Non digestible oligosaccharides modulate the gut microbiota to control the development of leukemia and associated cachexia in mice. PLoS ONE. 2015;10(6). https:\/\/doi.org\/10.1371\/journal.pone.0131009.","DOI":"10.1371\/journal.pone.0131009"},{"issue":"2","key":"791_CR94","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12016-023-08958-0","volume":"65","author":"T Shao","year":"2023","unstructured":"Shao T, Hsu R, Hacein-Bey C, Zhang W, Gao L, Kurth MJ, Zhao H, Shuai Z, Leung PSC. The evolving landscape of fecal microbial transplantation. Clin Rev Allergy Immunol. 2023;65(2):101. https:\/\/doi.org\/10.1007\/s12016-023-08958-0.","journal-title":"Clin Rev Allergy Immunol"},{"key":"791_CR95","doi-asserted-by":"publisher","unstructured":"Hu Y, Wang M, Liu J, Jiang H. A clinical controlled study of fecal microbiota transplantation in the treatment of advanced cancer with cachexia. Ann Oncol. 2022;33. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.1419.","DOI":"10.1016\/j.annonc.2022.07.1419"},{"key":"791_CR96","doi-asserted-by":"publisher","unstructured":"DeFilipp Z, Bloom PP, Soto MT, Mansour MK, Sater M, Huntley M, Turbett SE, Chung RT, Chen Y, Hohmann E. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med. 2019;381(21):2043. https:\/\/doi.org\/10.1056\/nejmoa1910437.","DOI":"10.1056\/nejmoa1910437"},{"key":"791_CR97","doi-asserted-by":"publisher","unstructured":"Hill C, Guarner F, Reid G. Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. 2014;11(8):506. https:\/\/doi.org\/10.1038\/nrgastro.2014.66.","DOI":"10.1038\/nrgastro.2014.66"},{"issue":"16","key":"791_CR98","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.3390\/nu15163655","volume":"15","author":"B Oberm\u00fcller","year":"2023","unstructured":"Oberm\u00fcller B, Singer G, Kienesberger B, Mittl B, Stadlbauer V, Horvath A, Miekisch W, Fuchs P, Schweiger M, Pajed L, Till H, Castellani C. Probiotic OMNi-BiOTiC\u00ae 10 AAD reduces Cyclophosphamide-Induced inflammation and adipose tissue wasting in mice. Nutrients. 2023;15(16):3655. https:\/\/doi.org\/10.3390\/nu15163655.","journal-title":"Nutrients"},{"key":"791_CR99","doi-asserted-by":"publisher","unstructured":"Bindels LB, Beck R, Schakman O, Martin JC, Backer FD, Sohet F, Dewulf E, Pachikian BD, Neyrinck AM, Thissen J, Verrax J, Calder\u00f3n PB, Pot B, Grangette C, Cani PD, Scott KP, Delzenne NM. Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLoS ONE. 2012;7(6). https:\/\/doi.org\/10.1371\/journal.pone.0037971.","DOI":"10.1371\/journal.pone.0037971"},{"issue":"7","key":"791_CR100","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/biomedicines12071450","volume":"12","author":"J-L Wang","year":"2024","unstructured":"Wang J-L, Chen Y-S, Huang K, Yeh C-H, Chen MC-M, Wu LS-H, Chiu Y. Resistant Starch-Encapsulated probiotics attenuate colorectal cancer cachexia and 5-Fluorouracil-Induced microbial dysbiosis. Biomedicines. 2024;12(7):1450. https:\/\/doi.org\/10.3390\/biomedicines12071450.","journal-title":"Biomedicines"},{"issue":"9","key":"791_CR101","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.3390\/ijms22094906","volume":"22","author":"IE Benito","year":"2021","unstructured":"Benito IE, Enc\u0131\u0301o I, Milagro FI, Alfaro M, Mart\u00ednez-pe\u00f1uela A, Barajas M, Marzo F. Microencapsulated bifidobacterium bifidum and Lactobacillus gasseri in combination with Quercetin inhibit colorectal cancer development in ApcMin\/+ mice. Int J Mol Sci. 2021;22(9):4906. https:\/\/doi.org\/10.3390\/ijms22094906.","journal-title":"Int J Mol Sci"},{"key":"791_CR102","doi-asserted-by":"publisher","unstructured":"Yeh K, Wang H, Chang JWC, Huang J, Lai C, Lan Y, Wu T, Chang P-H, Wang H, Wu C, Hsia S, Wang C. Omega-3 fatty acid-, micronutrient-, and probiotic-enriched nutrition helps body weight stabilization in head and neck cancer cachexia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(1):41. https:\/\/doi.org\/10.1016\/j.oooo.2013.01.015.","DOI":"10.1016\/j.oooo.2013.01.015"},{"key":"791_CR103","doi-asserted-by":"publisher","unstructured":"Nasrah R, Kanbalian M, Borch CVD, Dewar K, Chevalier S, Jagoe RT. Stool Microbiome features and weight change response to treatment for cancer cachexia. J Cachexia Sarcopenia Muscle. 2025;16(3). https:\/\/doi.org\/10.1002\/jcsm.13816.","DOI":"10.1002\/jcsm.13816"},{"issue":"7","key":"791_CR104","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1021\/acs.jproteome.4c00143","volume":"23","author":"M Simonson","year":"2024","unstructured":"Simonson M, Cueff G, Thibaut MM, Giraudet C, Salles J, Chambon C, Boirie Y, Bindels LB, Gueugneau M, Guillet C. Skeletal muscle proteome modifications following Antibiotic- induced microbial disturbances in cancer cachexia. J Proteome Res. 2024;23(7):2452. https:\/\/doi.org\/10.1021\/acs.jproteome.4c00143.","journal-title":"J Proteome Res"},{"key":"791_CR105","doi-asserted-by":"publisher","unstructured":"Al-Fakhrany OM, Elekhnawy E. Next-generation probiotics: the upcoming biotherapy. Mol Biol Rep. 2024;51(1). https:\/\/doi.org\/10.1007\/s11033-024-09398-5.","DOI":"10.1007\/s11033-024-09398-5"},{"key":"791_CR106","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4364001\/v1","author":"E Rampanelli","year":"2025","unstructured":"Rampanelli E, Romp N, Troise AD, Ananthasabesan J, Wu H, G\u00fcl IS, Pascale SD, Scaloni A, B\u00e4ckhed F, Fogliano V, Nieuwdorp M, Bui TPN. Gut bacterium intestinimonas butyriciproducens improves host metabolic health: evidence from cohort and animal intervention studies. Res Square (Research Square). 2025. https:\/\/doi.org\/10.21203\/rs.3.rs-4364001\/v1.","journal-title":"Res Square (Research Square)"},{"issue":"6","key":"791_CR107","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1089\/jmf.2021.k.0148","volume":"25","author":"HR Byeon","year":"2022","unstructured":"Byeon HR, Jang S-Y, Lee Y, Kim D, Hong M-G, Lee DK, Shin J, Seo J. New strains of Akkermansia muciniphila and Faecalibacterium Prausnitzii are effective for improving the muscle strength of mice with Immobilization-Induced muscular atrophy. J Med Food. 2022;25(6):565. https:\/\/doi.org\/10.1089\/jmf.2021.k.0148.","journal-title":"J Med Food"},{"key":"791_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/bit.28972","author":"X Qiu","year":"2025","unstructured":"Qiu X, Zou Z, Lin T, Guo C, Lin D. Engineered Lactobacillus rhamnosus producing 3-Hydroxybutyrate: A Dual\u2010Action therapeutic strategy for colon cancer cachexia. Biotechnol Bioeng. 2025. https:\/\/doi.org\/10.1002\/bit.28972.","journal-title":"Biotechnol Bioeng"},{"key":"791_CR109","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.coph.2019.07.005","volume":"49","author":"JF V\u00e1zquez-Castellanos","year":"2019","unstructured":"V\u00e1zquez-Castellanos JF, Biclot A, Vrancken G, Huys G, Raes J. Design of synthetic microbial consortia for gut microbiota modulation. Curr Opin Pharmacol. 2019;49:52. https:\/\/doi.org\/10.1016\/j.coph.2019.07.005.","journal-title":"Curr Opin Pharmacol"},{"key":"791_CR110","doi-asserted-by":"publisher","unstructured":"Falcinelli S, Rodiles A, Hatef A, Picchietti S, Cossignani L, Merrifield DL, Unniappan S, Carnevali O. Influence of probiotics administration on gut microbiota: a review on the effects on appetite control, glucose, and lipid metabolism. J Clin Gastroenterol. 2018;52. https:\/\/doi.org\/10.1097\/mcg.0000000000001064.","DOI":"10.1097\/mcg.0000000000001064"},{"issue":"2","key":"791_CR111","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/jcsm.12684","volume":"12","author":"SA P\u00f6tgens","year":"2021","unstructured":"P\u00f6tgens SA, Thibaut MM, Joudiou N, Sboarina M, Neyrinck AM, Cani PD, Claus SP, Delzenne NM, Bindels LB. Multi-compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice. J Cachexia Sarcopenia Muscle. 2021;12(2):456. https:\/\/doi.org\/10.1002\/jcsm.12684.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"791_CR112","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/jcsm.13465","volume":"15","author":"P Cui","year":"2024","unstructured":"Cui P, Li X, Huang C, Lin D. Metabolomics-driven discovery of therapeutic targets for cancer cachexia. J Cachexia Sarcopenia Muscle. 2024;15(3):781. https:\/\/doi.org\/10.1002\/jcsm.13465.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"791_CR113","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3390\/biom13091330","volume":"13","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Lu R, Lin F, Chen S, He Q-Q, Wu G, Huang C, Lin D. Exploring the therapeutic potential of Ethyl 3-Hydroxybutyrate in alleviating skeletal muscle wasting in cancer cachexia. Biomolecules. 2023;13(9):1330. https:\/\/doi.org\/10.3390\/biom13091330.","journal-title":"Biomolecules"},{"issue":"14","key":"791_CR114","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.3390\/nu16142322","volume":"16","author":"TPN Bui","year":"2024","unstructured":"Bui TPN. The human Microbiome as a therapeutic target for metabolic diseases. Nutrients. 2024;16(14):2322. https:\/\/doi.org\/10.3390\/nu16142322.","journal-title":"Nutrients"},{"key":"791_CR115","doi-asserted-by":"publisher","unstructured":"Lu S, Wang C, Ma J, Wang Y. Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy. Front Immunol. 2024;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1456030.","DOI":"10.3389\/fimmu.2024.1456030"},{"key":"791_CR116","doi-asserted-by":"publisher","unstructured":"Zhang F-L, Chen X, Wang Y, Hu Z, Zhang W, Zhou B, Ci P-F, Liu K. Microbiota-derived tryptophan metabolites indole-3-lactic acid is associated with intestinal ischemia\/reperfusion injury via positive regulation of YAP and Nrf2. J Trans Med. 2023;21(1). https:\/\/doi.org\/10.1186\/s12967-023-04109-3.","DOI":"10.1186\/s12967-023-04109-3"},{"key":"791_CR117","doi-asserted-by":"publisher","unstructured":"Li M, Ding Y, Wei J, Dong Y, Wang J, Dai X, Yan J, Chu F, Zhang K, Meng F, Ma J, Zhong W, Wang B, Gao Y, Yang R, Liu X, Su L, Cao H. Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation. Gut Microbes. 2024;16(1). https:\/\/doi.org\/10.1080\/19490976.2024.2377576.","DOI":"10.1080\/19490976.2024.2377576"},{"issue":"1","key":"791_CR118","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/rco2.28","volume":"4","author":"M Kanou","year":"2020","unstructured":"Kanou M, Nakamura K, Horie K, Sakai H, Yanagihara Y, Sakakibara I, Yamana K, Imai Y. Polyamine pathway is associated with muscle anabolic effects by androgen receptor ligand. JCSM Rapid Commun. 2020;4(1):57. https:\/\/doi.org\/10.1002\/rco2.28.","journal-title":"JCSM Rapid Commun"},{"issue":"5","key":"791_CR119","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/nutrit\/nux001","volume":"75","author":"MI Bhat","year":"2017","unstructured":"Bhat MI, Kapila R. Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals. Nutr Rev. 2017;75(5):374. https:\/\/doi.org\/10.1093\/nutrit\/nux001.","journal-title":"Nutr Rev"}],"container-title":["Genes &amp; Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12263-025-00791-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12263-025-00791-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12263-025-00791-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:52:26Z","timestamp":1766055146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12263-025-00791-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["791"],"URL":"https:\/\/doi.org\/10.1186\/s12263-025-00791-8","relation":{},"ISSN":["1555-8932","1865-3499"],"issn-type":[{"value":"1555-8932","type":"print"},{"value":"1865-3499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}